These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 27039993)
41. Combination of acid phosphatase positivity and rimmed vacuoles as useful markers in the diagnosis of adult-onset Pompe disease lacking specific clinical and pathological features. Dolfus C; Simon JP; Landemore G; Leroy F; Chapon F Folia Neuropathol; 2016; 54(3):295-302. PubMed ID: 27764522 [TBL] [Abstract][Full Text] [Related]
42. Making diagnosis of Pompe disease at a presymptomatic stage: to treat or not to treat? Laloui K; Wary C; Carlier RY; Hogrel JY; Caillaud C; Laforêt P Neurology; 2011 Aug; 77(6):594-5. PubMed ID: 21753173 [No Abstract] [Full Text] [Related]
43. Synergistic Efficacy from Gene Therapy with Coreceptor Blockade and a β2-Agonist in Murine Pompe Disease. Han SO; Li S; Bird A; Koeberl D Hum Gene Ther; 2015 Nov; 26(11):743-50. PubMed ID: 26417913 [TBL] [Abstract][Full Text] [Related]
44. [Diagnosis and therapy of late onset Pompe disease]. Schüller A; Kornblum C; Deschauer M; Vorgerd M; Schrank B; Mengel E; Lukacs Z; Gläser D; Young P; Plöckinger U; Schoser B Nervenarzt; 2013 Dec; 84(12):1467-72. PubMed ID: 24264645 [TBL] [Abstract][Full Text] [Related]
45. A novel mutation of the GAA gene in a Finnish late-onset Pompe disease patient: clinical phenotype and follow-up with enzyme replacement therapy. Korpela MP; Paetau A; Löfberg MI; Timonen MH; Lamminen AE; Kiuru-Enari SM Muscle Nerve; 2009 Jul; 40(1):143-8. PubMed ID: 19472353 [TBL] [Abstract][Full Text] [Related]
46. Genetic heterozygosity and pseudodeficiency in the Pompe disease newborn screening pilot program. Labrousse P; Chien YH; Pomponio RJ; Keutzer J; Lee NC; Akmaev VR; Scholl T; Hwu WL Mol Genet Metab; 2010 Apr; 99(4):379-83. PubMed ID: 20080426 [TBL] [Abstract][Full Text] [Related]
48. Transcriptional response to GAA deficiency (Pompe disease) in infantile-onset patients. Palermo AT; Palmer RE; So KS; Oba-Shinjo SM; Zhang M; Richards B; Madhiwalla ST; Finn PF; Hasegawa A; Ciociola KM; Pescatori M; McVie-Wylie AJ; Mattaliano RJ; Madden SL; Marie SK; Klinger KW; Pomponio RJ Mol Genet Metab; 2012 Jul; 106(3):287-300. PubMed ID: 22658377 [TBL] [Abstract][Full Text] [Related]
49. Nosology of lysosomal glycogen storage diseases without in vitro acid maltase deficiency. Delineation of a neonatal form. Verloes A; Massin M; Lombet J; Grattagliano B; Soyeur D; Rigo J; Koulischer L; Van Hoof F Am J Med Genet; 1997 Oct; 72(2):135-42. PubMed ID: 9382133 [TBL] [Abstract][Full Text] [Related]
50. Diagnostic criteria for late-onset (childhood and adult) Pompe disease. American Association of Neuromuscular & Electrodiagnostic Medicine Muscle Nerve; 2009 Jul; 40(1):149-60. PubMed ID: 19533647 [TBL] [Abstract][Full Text] [Related]
52. Next generation sequencing detection of late onset pompe disease. Angelini C; Savarese M; Fanin M; Nigro V Muscle Nerve; 2016 Jun; 53(6):981-3. PubMed ID: 26800218 [TBL] [Abstract][Full Text] [Related]
53. Pompe disease: An Indian series diagnosed on muscle biopsy by ultrastructural characterization. Kakkar A; Sharma MC; Nambirajan A; Gulati S; Bhatia R; Suri V; Sarkar C Ultrastruct Pathol; 2018; 42(3):211-219. PubMed ID: 29565761 [TBL] [Abstract][Full Text] [Related]
54. Newborn screening for Pompe disease in Japan. Oda E; Tanaka T; Migita O; Kosuga M; Fukushi M; Okumiya T; Osawa M; Okuyama T Mol Genet Metab; 2011 Dec; 104(4):560-5. PubMed ID: 21963784 [TBL] [Abstract][Full Text] [Related]
55. Correction of glycogen storage disease type II by an adeno-associated virus vector containing a muscle-specific promoter. Sun B; Zhang H; Franco LM; Brown T; Bird A; Schneider A; Koeberl DD Mol Ther; 2005 Jun; 11(6):889-98. PubMed ID: 15922959 [TBL] [Abstract][Full Text] [Related]
57. Pain in adult patients with Pompe disease: a cross-sectional survey. Güngör D; Schober AK; Kruijshaar ME; Plug I; Karabul N; Deschauer M; van Doorn PA; van der Ploeg AT; Schoser B; Hanisch F Mol Genet Metab; 2013 Aug; 109(4):371-6. PubMed ID: 23849261 [TBL] [Abstract][Full Text] [Related]
58. Akt inactivation induces endoplasmic reticulum stress-independent autophagy in fibroblasts from patients with Pompe disease. Nishiyama Y; Shimada Y; Yokoi T; Kobayashi H; Higuchi T; Eto Y; Ida H; Ohashi T Mol Genet Metab; 2012 Nov; 107(3):490-5. PubMed ID: 23041259 [TBL] [Abstract][Full Text] [Related]
59. Fibromyalgia-like symptoms associated with irritable bowel syndrome: A challenging diagnosis of late-onset Pompe disease. Gesquière-Dando A; Attarian S; Maues De Paula A; Pouget J; Salort-Campana E Muscle Nerve; 2015 Aug; 52(2):300-4. PubMed ID: 25703594 [TBL] [Abstract][Full Text] [Related]
60. Clinical features and predictors for disease natural progression in adults with Pompe disease: a nationwide prospective observational study. van der Beek NA; de Vries JM; Hagemans ML; Hop WC; Kroos MA; Wokke JH; de Visser M; van Engelen BG; Kuks JB; van der Kooi AJ; Notermans NC; Faber KG; Verschuuren JJ; Reuser AJ; van der Ploeg AT; van Doorn PA Orphanet J Rare Dis; 2012 Nov; 7():88. PubMed ID: 23147228 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]